Accessibility Tools

Chronic Rhinosinusitis (CRS) with Nasal Polyposis

AstraZenecaLogoAstraZeneca WAYPOINT

  • Candidates must be over 18 years of age
  • Must have CRS with Nasal Polyposis for at least 12 months
  • Any use of allergen immunotherapy must be in stable maintenance therapy for more than 30 days
  • Cannot have HIV, Hepatitis B or C
  • Not currently on a biologic treatment
    • Length: 69 weeks or 81 weeks depending on assigned group (treatment or placebo)
    • Number of visits: approx. 21
    • Compensation for time and travel

For more information:

Drs. Nathan Nachlas and Melyssa Hancock – Boca Raton office
contact Sandy DiBattista at 561-939-0186 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

Dr. Lee Mandel – Fort Lauderdale office
contact Sandy DiBattista at 561-939-0186 or email This email address is being protected from spambots. You need JavaScript enabled to view it.